Geratherm Medical AG (ETR:GME)
Germany · Delayed Price · Currency is EUR 2.450
0.00 (0.00%)
Sep 16, 2026, 9:02 AM CET
Geratherm Medical AG Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 13 | 16 | 19 | 29 | 27 | 41 | |
Market Cap Growth | -21.47% | -16.44% | -36.13% | 7.87% | -34.50% | -23.12% |
Enterprise Value | 6 | 8 | 19 | 27 | 27 | 44 |
Last Close Price | 2.45 | 2.78 | 3.25 | 4.92 | 4.44 | 7.34 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 26.55 | 26.38 | 26.55 | 339.35 |
Forward PE | - | 82.57 | 87.00 | 19.64 | 55.43 | 20.31 |
PS Ratio | 0.95 | 1.02 | 1.28 | 1.34 | 1.03 | 1.69 |
PB Ratio | 0.70 | 0.80 | 0.90 | 1.30 | 1.22 | 2.23 |
P/TBV Ratio | 0.75 | 0.87 | 0.96 | 1.66 | 1.49 | 2.39 |
P/FCF Ratio | 31.64 | 13.70 | 11.18 | 41.05 | 42.26 | 231.74 |
P/OCF Ratio | 21.46 | 11.99 | 10.03 | 19.91 | 9.76 | 45.24 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.44 | 0.55 | 1.31 | 1.24 | 1.04 | 1.78 |
EV/EBITDA Ratio | - | 43.09 | 5.91 | 7.04 | 7.34 | 24.35 |
EV/EBIT Ratio | - | - | 13.85 | 12.79 | 12.12 | 89.98 |
EV/FCF Ratio | 14.74 | 7.36 | 11.45 | 37.78 | 42.65 | 244.18 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.12 | 0.13 | 0.16 | 0.32 | 0.42 | 0.50 |
Debt / EBITDA Ratio | - | 12.69 | 1.01 | 1.89 | 2.49 | 4.39 |
Debt / FCF Ratio | 5.23 | 2.17 | 1.96 | 10.13 | 14.46 | 52.07 |
Net Debt / Equity Ratio | -0.35 | -0.35 | -0.31 | -0.02 | -0.07 | 0.15 |
Net Debt / EBITDA Ratio | 59.32 | -34.79 | -1.96 | -0.13 | -0.43 | 1.59 |
Net Debt / FCF Ratio | -15.80 | -5.94 | -3.80 | -0.72 | -2.47 | 15.93 |
Asset Turnover | 0.53 | 0.56 | 0.46 | 0.59 | 0.72 | 0.70 |
Inventory Turnover | 1.19 | 1.28 | 1.08 | 0.62 | 1.30 | 1.11 |
Quick Ratio | 7.44 | 2.51 | 5.25 | 2.73 | 3.40 | 1.27 |
Current Ratio | 11.70 | 3.88 | 8.84 | 5.97 | 5.41 | 2.33 |
Return on Equity (ROE) | -5.17% | -4.11% | 3.01% | 7.43% | 5.30% | 1.73% |
Return on Assets (ROA) | -2.94% | -2.21% | 2.69% | 3.56% | 3.88% | 0.86% |
Return on Invested Capital (ROIC) | -10.13% | -7.11% | 5.10% | 7.11% | 6.79% | 2.34% |
Return on Capital Employed (ROCE) | -5.20% | -4.40% | 5.20% | 6.50% | 6.60% | 1.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -6.44% | -5.24% | 3.77% | 3.79% | 3.77% | 0.29% |
FCF Yield | 3.16% | 7.30% | 8.94% | 2.44% | 2.37% | 0.43% |
Dividend Yield | 4.05% | 3.59% | 3.08% | 2.03% | 3.38% | 1.64% |
Payout Ratio | - | - | 76.72% | 73.17% | 63.80% | 1619.83% |
Buyback Yield / Dilution | - | - | - | 0.61% | -10.00% | - |
Total Shareholder Return | 4.05% | 3.59% | 3.08% | 2.64% | -6.62% | 1.64% |